2nd Quarter - Report

NOVOCURE INC. for NOVOCURE INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$110,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2023 $110,000 Replaced
2nd Quarter - Amendment Aug 2, 2023 $180,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General Medicare Issues. H.R.1691 - Ensuring Patient Access to Critical Breakthrough Products Act of 2023.

Foreign entity interest: Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.

LobbyistCovered position, as disclosed
EMILY HAAS Senior Policy Advisor, Congressman Conor Lamb; Legislative Aide for Congresswoman Allyson Schwartz
KATHERINE MEYER Senior Policy Advisor, Office of House Republican Leader Kevin McCarthy; Deputy Health Policy Director, Senate Finance Committee; Health Policy Advisor, Senator Orrin Hatch; Sr. LA, Congressman Erik Paulsen; LA, Congressman Jeff Fortenberry
ZARIA SMITH New —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 1691 (118th)

Veterans VET

Veteran Affairs Issues.

Foreign entity interest: Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.

LobbyistCovered position, as disclosed
EMILY HAAS —
KATHERINE MEYER —
ZARIA SMITH New —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Transportation TRA

TSA Issues.

Foreign entity interest: Novocure GmbH, Novocure Luxembourg S.a.r.l. (who owns 100% of Novocure GmbH) and NovoCure Limited (who owns 100% of Luxembourg S.a.r.l.), identified on filer's Registration Statement (LD-1), as its parent organization, has an interest in the listed issues.

LobbyistCovered position, as disclosed
EMILY HAAS —
KATHERINE MEYER —
ZARIA SMITH New —

Contacted: SENATE; Transportation Security Administration (TSA); HOUSE OF REPRESENTATIVES; Homeland Security, Dept of (DHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.